| 348P Long-term opioid use following treatment of localized breast cancer: A real-world analysis A Shai, E Granot-Hershkovitz, S Amar-Farkash, K Rosenberg-Katz, ... Annals of Oncology 34, S321, 2023 | | 2023 |
| 629: MFMU Calculator versus machine learning techniques for predicting VBAC success–Which model works best? R Meyer, N Hendin, M Zamir, NI Mor, E Sivan, YJ Blumenfeld, D Aran, ... American Journal of Obstetrics & Gynecology 222 (1), S401-S402, 2020 | 1 | 2020 |
| 651 Clinical efficacy of a machine learning model for prediction of shoulder dystocia MF Bartal, A Tsur, BM Sibai, D Aran, MJ Bicocca, SP Chauhan American Journal of Obstetrics & Gynecology 224 (2), S409, 2021 | 3 | 2021 |
| 657: Improving the prediction of shoulder dystocia using artificial intelligence–a novel approach A Tsur, L Batsry, O Barak, Y Brezinov, S Toussia-Cohen, R Yoeli-Ullman, ... American Journal of Obstetrics & Gynecology 220 (1), S435-S436, 2019 | | 2019 |
| Abstract TMP32: Transcriptome Changes of Brain Myeloid Cells After Ischemic Stroke in Type 2 Diabetic Mice S Omodaka, A Kanoke, S Wong, D Aran, J Liu Stroke 51 (Suppl_1), ATMP32-ATMP32, 2020 | | 2020 |
| Aging is associated with highly defined epigenetic changes in the human epidermis G Raddatz, S Hagemann, D Aran, J Söhle, PP Kulkarni, L Kaderali, ... Epigenetics & chromatin 6, 1-12, 2013 | 95 | 2013 |
| Cancer cell–autonomous parainflammation mimics immune cell infiltration A Lasry, D Aran, AJ Butte, Y Ben-Neriah Cancer research 77 (14), 3740-3744, 2017 | 18 | 2017 |
| CD161 contributes to prenatal immune suppression of IFN-γ–producing PLZF+ T cells J Halkias, E Rackaityte, SL Hillman, D Aran, VF Mendoza, LR Marshall, ... The Journal of clinical investigation 129 (9), 3562-3577, 2019 | 67 | 2019 |
| CD161 mediates prenatal immune suppression of IFNγ-producing PLZF+ T cells J Halkias, E Rackaityte, D Aran, VF Mendoza, WL Eckalbar, T Burt bioRxiv, 305128, 2018 | | 2018 |
| Cell-type enrichment analysis of bulk transcriptomes using xCell D Aran Bioinformatics for cancer immunotherapy: methods and protocols, 263-276, 2020 | 105 | 2020 |
| CNS fibroblasts form a fibrotic scar in response to immune cell infiltration CE Dorrier, D Aran, EA Haenelt, RN Sheehy, KK Hoi, L Pintarić, Y Chen, ... Nature neuroscience 24 (2), 234-244, 2021 | 141 | 2021 |
| Comparative Analysis of First-Line FOLFOX Treatment With and Without Anti-VEGF Therapy in Metastatic Colorectal Carcinoma: A Real-World Data Study R Brenner, S Amar-Farkash, A Klein-Brill, K Rosenberg-Katz, D Aran Cancer Control 30, 10732748231202470, 2023 | | 2023 |
| Comparative efficacy of combined CTLA-4 and PD-1 blockade vs. PD-1 monotherapy in metastatic melanoma: a real-world study A Klein-Brill, S Amar-Farkash, K Rosenberg-Katz, R Brenner, JC Becker, ... BJC Reports 2 (1), 14, 2024 | | 2024 |
| Comparison of FOLFIRINOX vs gemcitabine plus nab-paclitaxel as first-line chemotherapy for metastatic pancreatic ductal adenocarcinoma A Klein-Brill, S Amar-Farkash, G Lawrence, EA Collisson, D Aran JAMA network open 5 (6), e2216199-e2216199, 2022 | 39 | 2022 |
| Comprehensive analysis of normal adjacent to tumor transcriptomes D Aran, R Camarda, J Odegaard, H Paik, B Oskotsky, G Krings, A Goga, ... Nature communications 8 (1), 1077, 2017 | 494 | 2017 |
| Comprehensive transcriptomic analysis of cell lines as models of primary tumor samples across 22 tumor types K Yu, B Chen, D Aran, J Charalel, A Butte, T Goldstein, M Sirota bioRxiv, 422592, 2018 | 1 | 2018 |
| Comprehensive transcriptomic analysis of cell lines as models of primary tumors across 22 tumor types K Yu, B Chen, D Aran, J Charalel, C Yau, DM Wolf, LJ Van ‘T Veer, ... Nature communications 10 (1), 3574, 2019 | 131 | 2019 |
| Contribution of Epigenetic Variations at Distant Control Elements to the Etiology of Common Human Diseases D Aran Hebrew University of Jerusalem, 2014 | | 2014 |
| Cross-tissue analysis of gene and protein expression in normal and cancer tissues I Kosti, N Jain, D Aran, AJ Butte, M Sirota Scientific reports 6 (1), 24799, 2016 | 197 | 2016 |
| Defective interferon signaling in the circulating monocytes of type 2 diabetic mice S Omodaka, Y Kato, Y Sato, J Falcone-Juengert, H Zhang, A Kanoke, ... bioRxiv, 2024.06. 03.597050, 2024 | | 2024 |
Atul J. ButteDirector, Bakar Computational Health Sciences Institute, University of California, San Francisco在 ucsf.edu 的电子邮件经过验证
